A phase I/II study of Bicizar (C1-esterase inhibitor) in sepsis patients

Trial Profile

A phase I/II study of Bicizar (C1-esterase inhibitor) in sepsis patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Nov 2015

At a glance

  • Drugs Complement C1 inhibitor protein (Primary)
  • Indications Sepsis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2015 New trial record
    • 29 Nov 2006 According to Biogenius media release, the MOH state regulators of Russia approved to conduct this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top